CAMH donation gives mental health scientists a chance to harness data with artificial intelligence
Krembil family provides $15-million to establish world-leading neuroinformatics lab for brain researchers at Centre for Addiction and Mental Health
Amanda Lang interviews OBI President Dr. Tom Mikkelsen
In an interview with Bloomberg TV Canada’s Amanda Lang Dr. Tom Mikkelsen, OBI, President and Scientific Director speaks to the research they’re currently working on, to help alleviate the burden on our healthcare system from Ontario’s aging population.
Health & Community Leaders Talk: Dr. Tom Mikkelsen
Dr. Tom Mikkelsen describes how the Ontario Brain Institute's Brain-CODE data sharing platform contributes to a Healthier, Wealthier, Smarter Ontario.
Canadian neuroscience leaders tap IBM Watson to speed time to discovering new drugs for Parkinson's disease
Canadian neuroscience leaders tap IBM Watson to speed time to discovering new drugs for Parkinson’s disease
Canadian neuroscience leaders tap IBM Watson to speed time to discovering new drugs for Parkinson's
Oct. 12, 2016 /CNW/ - IBM (NYSE: IBM) Watson Health today announced that the Ontario Brain Institute (OBI) and the Movement Disorders Clinic (MDC) at University Health Network (UHN) will embark on first ever Parkinson's disease research project using the recently launched IBM Watson for Drug Discovery.